Form S-4 Bio Green Med Solution,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260616/AU229G2CZM2RKZUZ2K2N2ZY2K6TQRZ22Z282
Filed on: June 16, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia
- argenx to Host Autoimmune Myositis R&D Webinar
- Weekly progress on share repurchase program to cover share plans and reduce capital
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
